Pfizer/Biontech Seek FDA Authorization of Updated Covid-19 Vaccine for Children Under 5
12/5/2022
Pfizer/Biontech Seek FDA Authorization of Updated Covid-19 Vaccine for Children Under 5
Pfizer and BioNTech have submitted an application to the US Food and Drug Administration for their updated Covid-19 vaccine to be used as the third shot in the three-dose primary vaccine series for children ages 6 months through 4 years.
The vaccine makers announced on Monday that if authorized for emergency use, children in that age group will still receive the original version of the Covid-19 vaccine as their first two doses and then the updated Covid-19 vaccine – formulated to target the coronavirus Omicron subvariants BA.4 and BA.5 – as the third dose.
While the primary Covid-19 vaccine series for older children and adults involves receiving two doses of the Pfizer/BioNTech vaccine, a three-dose primary series has been the approach for children younger than 5.
The Omicron-adapted vaccine is currently authorized for emergency use in the United States as a booster dose for people 5 and older.
“With the high level of respiratory illnesses currently circulating among children under 5 years of age, updated COVID-19 vaccines may help prevent severe illness and hospitalization,” according to the companies’ announcement on Monday morning.
Full Link ( CNN ) Here
© CopyRights RawNews1st
